163 related articles for article (PubMed ID: 10411477)
1. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
[TBL] [Abstract][Full Text] [Related]
2. Novel euglycemic and hypolipidemic agents. 1.
Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
[TBL] [Abstract][Full Text] [Related]
3. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
[TBL] [Abstract][Full Text] [Related]
4. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
[TBL] [Abstract][Full Text] [Related]
5. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
Vikramadithyan RK; Chakrabarti R; Misra P; Premkumar M; Kumar SK; Rao CS; Ghosh A; Reddy KN; Uma C; Rajagopalan R
Metabolism; 2000 Nov; 49(11):1417-23. PubMed ID: 11092504
[TBL] [Abstract][Full Text] [Related]
6. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.
Shi GQ; Dropinski JF; McKeever BM; Xu S; Becker JW; Berger JP; MacNaul KL; Elbrecht A; Zhou G; Doebber TW; Wang P; Chao YS; Forrest M; Heck JV; Moller DE; Jones AB
J Med Chem; 2005 Jun; 48(13):4457-68. PubMed ID: 15974597
[TBL] [Abstract][Full Text] [Related]
8. Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of thiazolidinedione, DRF 2189.
Chakrabarti R; Vikramadithyan RK; Dileepkumar T; Kumar KB; Kumar MP; Misra P; Rao PB; Lohray VB; Lohray BB; Rajagopalan R
Arzneimittelforschung; 1999 Nov; 49(11):905-11. PubMed ID: 10604043
[TBL] [Abstract][Full Text] [Related]
9. Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.
Madhavan GR; Chakrabarti R; Reddy KA; Rajesh BM; Balraju V; Rao PB; Rajagopalan R; Iqbal J
Bioorg Med Chem; 2006 Jan; 14(2):584-91. PubMed ID: 16198573
[TBL] [Abstract][Full Text] [Related]
10. MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities.
Doebber TW; Kelly LJ; Zhou G; Meurer R; Biswas C; Li Y; Wu MS; Ippolito MC; Chao YS; Wang PR; Wright SD; Moller DE; Berger JP
Biochem Biophys Res Commun; 2004 May; 318(2):323-8. PubMed ID: 15120604
[TBL] [Abstract][Full Text] [Related]
11. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
Chakrabarti R; Misra P; Vikramadithyan RK; Premkumar M; Hiriyan J; Datla SR; Damarla RK; Suresh J; Rajagopalan R
Eur J Pharmacol; 2004 May; 491(2-3):195-206. PubMed ID: 15140637
[TBL] [Abstract][Full Text] [Related]
13. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents.
Gupta D; Ghosh NN; Chandra R
Bioorg Med Chem Lett; 2005 Feb; 15(4):1019-22. PubMed ID: 15686904
[TBL] [Abstract][Full Text] [Related]
15. (2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents.
Koyama H; Miller DJ; Boueres JK; Desai RC; Jones AB; Berger JP; MacNaul KL; Kelly LJ; Doebber TW; Wu MS; Zhou G; Wang PR; Ippolito MC; Chao YS; Agrawal AK; Franklin R; Heck JV; Wright SD; Moller DE; Sahoo SP
J Med Chem; 2004 Jun; 47(12):3255-63. PubMed ID: 15163205
[TBL] [Abstract][Full Text] [Related]
16. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety.
Collins JL; Blanchard SG; Boswell GE; Charifson PS; Cobb JE; Henke BR; Hull-Ryde EA; Kazmierski WM; Lake DH; Leesnitzer LM; Lehmann J; Lenhard JM; Orband-Miller LA; Gray-Nunez Y; Parks DJ; Plunkett KD; Tong WQ
J Med Chem; 1998 Dec; 41(25):5037-54. PubMed ID: 9836621
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
[TBL] [Abstract][Full Text] [Related]
19. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
Humphries PS; Bailey S; Almaden JV; Barnum SJ; Carlson TJ; Christie LC; Do QQ; Fraser JD; Hess M; Kellum J; Kim YH; McClellan GA; Ogilvie KM; Simmons BH; Skalitzky D; Sun S; Wilhite D; Zehnder LR
Bioorg Med Chem Lett; 2006 Dec; 16(23):6120-3. PubMed ID: 16973358
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives.
Madhavan GR; Chakrabarti R; Vikramadithyan RK; Mamidi RN; Balraju V; Rajesh BM; Misra P; Kumar SK; Lohray BB; Lohray VB; Rajagopalan R
Bioorg Med Chem; 2002 Aug; 10(8):2671-80. PubMed ID: 12057656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
